title: Belatacept: is there BENEFIT for liver transplantation too?
abstract: The results of the multicenter belatacept liver transplant trial disappoint with respect to safety and efficacy, and new approaches will be required before this agent plays a role in liver transplant immunosuppression. See article by Klintmalm et al on page 1817.
authors.forename: S J
authors.initials: SJ
authors.lastname: Knechtle
authors.forename: A B
authors.initials: AB
authors.lastname: Adams
mesh_terms: D000069594:Abatacept; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male
chemical_list: D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept